Clinical Trials in Atlanta

Showing 10761-10780 of 19,805 trials

Anti-LPS Antibody Treatment for Pediatric NAFLD

NCT03042767

The main objective of this pilot study is to evaluate whether 12 weeks of IMM-124E in children with nonalcoholic fatty liver disease (NAFLD) in combination with standard of care treatment will decrease inflammation in the liver as measured by alanine transaminase (ALT). Specifically, investigators will measure percent change in ALT from Week 0 to Week 12 in treatment compared to placebo.

Nonalcoholic Fatty Liver Disease (NAFLD)

Miriam Vos, MD40 participantsStarted Feb 2017

Atlanta, Georgia, United States

COMPLETEDPhase 3< 1 mile

Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor

NCT02544451

Study 110 is a Phase 3, multicenter study in subjects aged 6 years and older with cystic fibrosis (CF) who are homozygous for the F508del-CF transmembrane conductance regulator (CFTR) mutation and who participated in Study 109 (NCT02514473) or Study 011B (NCT01897233). Study 110 is designed to evaluate the safety and efficacy of long term treatment of lumacaftor in combination with ivacaftor.

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated246 participantsStarted Aug 2015

Birmingham, Alabama, United States • Tucson, Arizona, United States • Long Beach, California, United States +57 more locations

Anti-LPS Antibody Treatment for Pediatric NAFLD

Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor

Find Trials by Condition in Atlanta

Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU

Gammagard Liquid and rHuPH20 in PID

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Treatment Protocol of Replagal for Patients With Fabry Disease

Uphold LITE Post-Market Surveillance Study

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

BAX 855 Pediatric Study

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test

Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS